StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2022 - 11 - 10
1
2022 - 03 - 09
1
2021 - 11 - 10
1
2021 - 04 - 21
1
Sector
Health technology
4
Tags
Activmab
2
Alzheimer
2
Alzheimer's
2
Alzheimer's disease
2
Alzheimer’s
3
America
1
Antibody
2
Application
1
Cancer
4
Cell carcinoma
2
Ces
1
Clinical trials
1
Collaboration
1
Commercialization
1
Communications
1
Conference
6
Dating
1
Disease
6
Drug
1
Ema
1
Enroll
1
Europe
1
Financial
2
Financial results
3
Huntington
4
Huntington’s disease
2
Immunotherapy
2
International
1
Keytruda
3
Lung cancer
1
Meeting
1
N/a
33
Pepinemab
8
Phase 1
2
Phase 1b
2
Phase 2
1
Phase 2b
2
Potential
1
Presentation
6
Research
2
Results
7
Study
3
Technology
1
Therapy
1
Topline
1
Trial
2
Trials
2
Update
2
Vaccine
19
Entities
Vaccinex, inc.
4
Symbols
VCNX
4
Exchanges
Nasdaq
4
Crawled Date
2022 - 11 - 10
1
2022 - 03 - 12
1
2021 - 11 - 13
1
2021 - 04 - 21
1
Crawled Time
12:15
1
14:00
1
16:20
2
Source
adnas.com
1
contravir.com
3
immunitybio.com
1
investor.alkermes.com
7
investor.aveooncology.com
2
investors.phiopharma.com
6
investors.senseibio.com
8
ir.anaptysbio.com
3
ir.biolinerx.com
5
ir.chemocentryx.com
1
ir.hoththerapeutics.com
4
ir.vaccinex.com
4
jaguarhealth.gcs-web.com
27
mdxhealth.com
8
myriad.com
1
nanthealth.com
7
renovorx.com
12
salariuspharma.com
1
spacfeed.com
9
www.4frontventures.com
1
www.accuray.com
1
www.adnas.com
1
www.affimed.com
2
www.allogene.com
3
www.atossatherapeutics.com
2
www.beyondspringpharma.com
4
www.biospace.com
1891
www.celyad.com
2
www.chi-med.com
2
www.cuebiopharma.com
1
www.curevac.com
1
www.emmis.com
1
www.fatetherapeutics.com
9
www.fda.gov
30
www.gflenv.com
1
www.globenewswire.com
1244
www.hepionpharma.com
2
www.hutch-med.com
2
www.igmbio.com
2
www.immatics.com
3
www.immunogen.com
5
www.immunoprecise.com
2
www.innodata.com
1
www.j2global.com
1
www.kuraoncology.com
9
www.limoneira.com
4
www.luminexcorp.com
1
www.mdu.com
1
www.myriad.com
5
www.nanthealth.com
5
www.nantkwest.com
14
www.novocure.com
5
www.nurixtx.com
5
www.phiopharma.com
1
www.poseida.com
6
www.precisionbiosciences.com
1
www.prnewswire.com
876
www.profoundmedical.com
1
www.sutrobio.com
10
www.vermillion.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Cancer
source :
Ir.vaccinex.com
save search
Vaccinex and its Collaborators Present Two Abstracts Related to Pepinemab Combination Immunotherapy Trials at 37th Annual Meeting of Society for Immunotherapy of Cancer
Published:
2022-11-10
(Crawled : 14:00)
- ir.vaccinex.com
VCNX
|
$4.8
-2.76%
7.9K
|
Health Technology
|
737.99%
|
O:
3.0%
H:
6.78%
C:
1.69%
trials
immunotherapy
meeting
pepinemab
cancer
Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Meta
Published:
2022-03-09
(Crawled : 16:20)
- ir.vaccinex.com
VCNX
|
$4.8
-2.76%
7.9K
|
Health Technology
|
340.37%
|
O:
1.83%
H:
18.92%
C:
17.12%
america
ema
phase 1b
research
presentation
pepinemab
phase 1
keytruda
dating
cancer
vaccine
phase 2b
Vaccinex, Inc. to Present at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published:
2021-11-10
(Crawled : 16:20)
- ir.vaccinex.com
VCNX
|
$4.8
-2.76%
7.9K
|
Health Technology
|
134.15%
|
O:
-1.46%
H:
3.47%
C:
-1.49%
immunotherapy
therapy
cancer
vaccine
Vaccinex Announces Publication of Results from CLASSICAL-Lung Phase 1b/2 Clinical Trial in Non-Small Cell Lung Cancer in the Peer-Reviewed Journal Clinical Cancer Research
Published:
2021-04-21
(Crawled : 12:15)
- ir.vaccinex.com
VCNX
|
$4.8
-2.76%
7.9K
|
Health Technology
|
106.9%
|
O:
1.72%
H:
7.2%
C:
5.51%
lung cancer
phase 1
results
cancer
vaccine
research
trial
phase 1b
phase 2b
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.